دورية أكاديمية

Evaluation of Xpert MTB/RIF Ultra for the Diagnosis of Extrapulmonary Tuberculosis: A Retrospective Analysis in Saudi Arabia.

التفاصيل البيبلوغرافية
العنوان: Evaluation of Xpert MTB/RIF Ultra for the Diagnosis of Extrapulmonary Tuberculosis: A Retrospective Analysis in Saudi Arabia.
المؤلفون: Slail MJ; Tuberculosis Department, Dammam Regional Laboratory, Ministry of Health, Dammam, Saudi Arabia., Booq RY; Wellness and Preventive Medicine Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), 11442, Riyadh, Saudi Arabia., Al-Ahmad IH; Tuberculosis Department, Dammam Regional Laboratory, Ministry of Health, Dammam, Saudi Arabia., Alharbi AA; Mycobacteriology Unit, Riyadh Regional Laboratory, Ministry of Health, 12746, Riyadh, Saudi Arabia., Alharbi SF; Mycobacteriology Unit, Riyadh Regional Laboratory, Ministry of Health, 12746, Riyadh, Saudi Arabia., Alotaibi MZ; Mycobacteriology Unit, Riyadh Regional Laboratory, Ministry of Health, 12746, Riyadh, Saudi Arabia., Aljubran AM; Mycobacteriology Unit, Riyadh Regional Laboratory, Ministry of Health, 12746, Riyadh, Saudi Arabia., Aldossary AM; Wellness and Preventive Medicine Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), 11442, Riyadh, Saudi Arabia., Memish ZA; College of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia.; Research & Innovation Center, King Saud Medical City, Riyadh, Saudi Arabia.; Hubert Department School of Public Health, Emory University, Atlanta, USA.; Division of Infectious Diseases, Kyung Hee University, Seoul, Korea., Alyamani EJ; Wellness and Preventive Medicine Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), 11442, Riyadh, Saudi Arabia., Tawfik EA; Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), 11442, Riyadh, Saudi Arabia. etawfik@kacst.edu.sa., Binjomah AZ; Mycobacteriology Unit, Riyadh Regional Laboratory, Ministry of Health, 12746, Riyadh, Saudi Arabia. abinjomah@moh.gov.sa.; College of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia. abinjomah@moh.gov.sa.
المصدر: Journal of epidemiology and global health [J Epidemiol Glob Health] 2023 Dec; Vol. 13 (4), pp. 782-793. Date of Electronic Publication: 2023 Sep 14.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: Switzerland NLM ID: 101592084 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-6014 (Electronic) Linking ISSN: 22106006 NLM ISO Abbreviation: J Epidemiol Glob Health Subsets: MEDLINE
أسماء مطبوعة: Publication: 2021- : [Cham] : Springer
Original Publication: Amsterdam : Elsevier, [2011]-
مواضيع طبية MeSH: Tuberculosis, Pulmonary*/diagnosis , Mycobacterium tuberculosis*/genetics , Antibiotics, Antitubercular*/pharmacology , Tuberculosis, Extrapulmonary*, Humans ; Rifampin/therapeutic use ; Retrospective Studies ; Saudi Arabia ; Sensitivity and Specificity ; Drug Resistance, Bacterial ; Sputum/microbiology
مستخلص: The incidence of extrapulmonary tuberculosis (EPTB) in low- and middle-income countries, as well as, high-income countries has increased over the last two decades. The acid-fast bacillus (AFB) smear test is easy to perform and cost-effective with a quick turnaround time but the test has low sensitivity. Culture remains the gold standard for detecting TB; however, it has low sensitivity and slow bacterial growth patterns, as it may take up to 6 to 8 weeks to grow. Therefore, a rapid detection tool is crucial for the early initiation of treatment and ensuring an improved therapeutic outcome. Here, the Xpert Ultra system was developed as a nucleic acid amplification technique to accelerate the detection of MTB in paucibacillary clinical samples and endorsed by the World Health Organization. From March 2020 to August 2021, Xpert Ultra was evaluated for its sensitivity and specificity against EPTB and compared with those of the routinely used Xpert, culture, and AFB tests in 845 clinical samples in Saudi Arabia. The results indicate the overall sensitivity and specificity of Xpert Ultra to be 91% and 95%, respectively, compared with the Xpert (82% and 99%, respectively) and AFB smear (18% and 100%, respectively) tests. The results also indicated that despite the low microbial loads that were categorized as trace, very low, or low on Xpert Ultra, yet, complete detection was achieved with some sample types (i.e., 100% detection). Consequently, Xpert Ultra has great potential to replace conventional diagnostic approaches as a standard detection method for EPTB.
(© 2023. The Author(s).)
References: J Microbiol Methods. 2008 Aug;74(2-3):119-20. (PMID: 18513812)
Ann Thorac Med. 2013 Jul;8(3):148-52. (PMID: 23922609)
Cochrane Database Syst Rev. 2019 Jun 07;6:CD009593. (PMID: 31173647)
Clin Microbiol Infect. 2022 Aug;28(8):1150.e1-1150.e6. (PMID: 35358686)
J Infect. 2019 Aug;79(2):153-158. (PMID: 31207324)
Sci Rep. 2020 Aug 18;10(1):13959. (PMID: 32811871)
Int J Tuberc Lung Dis. 2021 Aug 1;25(8):626-631. (PMID: 34330347)
Pediatr Allergy Immunol. 2022 Jan;33 Suppl 27:80-82. (PMID: 35080295)
mBio. 2017 Aug 29;8(4):. (PMID: 28851844)
Semin Immunopathol. 2019 Mar;41(2):225-237. (PMID: 30361803)
J Clin Microbiol. 2010 Jan;48(1):229-37. (PMID: 19864480)
Infect Drug Resist. 2020 Nov 10;13:4031-4038. (PMID: 33204120)
Int J Infect Dis. 2022 Sep;122:741-746. (PMID: 35872095)
Cochrane Database Syst Rev. 2018 Aug 27;8:CD012768. (PMID: 30148542)
PLoS One. 2010 Jun 14;5(6):e11108. (PMID: 20559431)
N Engl J Med. 2010 Sep 9;363(11):1005-15. (PMID: 20825313)
Int J Environ Res Public Health. 2021 Sep 24;18(19):. (PMID: 34639342)
Diagn Microbiol Infect Dis. 2021 May;100(1):115306. (PMID: 33516988)
Euro Surveill. 2013 Mar 21;18(12):. (PMID: 23557946)
Eur J Clin Microbiol Infect Dis. 2020 Aug;39(8):1597-1600. (PMID: 32232690)
Exp Ther Med. 2018 Sep;16(3):2770-2776. (PMID: 30210618)
Lancet Microbe. 2022 Jul;3(7):e521-e532. (PMID: 35644157)
Antimicrob Agents Chemother. 2007 Sep;51(9):3338-45. (PMID: 17517834)
Expert Rev Anti Infect Ther. 2021 Jan;19(1):65-77. (PMID: 32806986)
Microbiol Spectr. 2022 Jun 29;10(3):e0234521. (PMID: 35471095)
Saudi J Biol Sci. 2021 Aug;28(8):4103-4108. (PMID: 34354388)
Clin Infect Dis. 2004 Jan 15;38(2):199-205. (PMID: 14699451)
Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):601-605. (PMID: 30680567)
Cochrane Database Syst Rev. 2021 Mar 23;3:CD013694. (PMID: 33755189)
J Clin Microbiol. 2011 Dec;49(12):4138-41. (PMID: 21956978)
Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009593. (PMID: 23440842)
Eur Respir J. 2012 Aug;40(2):442-7. (PMID: 22241741)
PLoS One. 2021 Apr 8;16(4):e0249734. (PMID: 33831077)
Nat Rev Neurol. 2017 Oct;13(10):581-598. (PMID: 28884751)
Saudi Med J. 2021 Jul;42(7):728-734. (PMID: 34187916)
Lancet Infect Dis. 2018 Jan;18(1):76-84. (PMID: 29198911)
Lancet Infect Dis. 2018 Jan;18(1):68-75. (PMID: 28919338)
Thorax. 2013 Mar;68(3):290-1. (PMID: 22863812)
Int J Infect Dis. 2019 Apr;81:91-96. (PMID: 30738907)
Clin Infect Dis. 2009 Nov 1;49(9):1350-7. (PMID: 19793000)
Infect Dis (Lond). 2020 Nov;52(11):763-775. (PMID: 32619114)
PLoS One. 2012;7(2):e31563. (PMID: 22347495)
Chest. 2020 Feb;157(2):268-275. (PMID: 31437432)
BMC Med. 2013 Aug 29;11:190. (PMID: 23987891)
Int J Infect Dis. 2020 Jan;90:35-45. (PMID: 31546008)
Lancet Infect Dis. 2020 Mar;20(3):299-307. (PMID: 31924551)
فهرسة مساهمة: Keywords: Extrapulmonary tuberculosis; Pulmonary tuberculosis; Rapid detection; Real-time polymerase chain reaction (RT-PCR); Saudi Arabia; Xpert Ultra
المشرفين على المادة: VJT6J7R4TR (Rifampin)
0 (Antibiotics, Antitubercular)
تواريخ الأحداث: Date Created: 20230914 Date Completed: 20231130 Latest Revision: 20231201
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10686912
DOI: 10.1007/s44197-023-00150-z
PMID: 37707714
قاعدة البيانات: MEDLINE
الوصف
تدمد:2210-6014
DOI:10.1007/s44197-023-00150-z